Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
BACKGROUND: Breast cancer (BC) is a heterogeneous disease, and patients with apparently similar clinicopathological characteristics in clinical practice show different outcome. This study evaluated in primary BCs and in the subgroup of the triple-negative breast cancers (TNBCs) the level of tumor in...
Main Authors: | Laura Schirosi, Concetta Saponaro, Francesco Giotta, Ondina Popescu, Maria Irene Pastena, Emanuela Scarpi, Anita Mangia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523319303213 |
Similar Items
-
Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
by: Anita Mangia, et al.
Published: (2019-09-01) -
Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients
by: Concetta Saponaro, et al.
Published: (2019-07-01) -
Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
by: Miao Qin, et al.
Published: (2022-06-01) -
Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01) -
The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer
by: Ying Sun, et al.
Published: (2022-10-01)